Orphan Drug Innovation Act
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 24, 2000
Referred to the Subcommittee on Health and Environment.
Apr 11, 2000
Referred to the House Committee on Commerce.
Apr 11, 2000
Introduced in House
Ask about this bill
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Plain-English summary
Orphan Drug Innovation Act - Amends the Federal Food, Drug and Cosmetic Act, with respect to orphan drugs, to provide for the waiver of the seven-year prohibition against approval for a drug which is clinically superior to an approved drug.
What's happening now
Referred to the Subcommittee on Health and Environment.
Bill text
1 version
- Introduced in House Formatted Text PDF
Committees of jurisdiction
2
Cosponsors
1
Cite this page
U.S. Congress. (2026). H.R. 4242: Orphan Drug Innovation Act. 106th Congress. Open America. https://openamerica.io/bill/106-HR-4242/
"H.R. 4242: Orphan Drug Innovation Act." 106th Congress, 2026, Open America, https://openamerica.io/bill/106-HR-4242/.
H.R. 4242, 106th Cong. (2026), https://openamerica.io/bill/106-HR-4242/.
[H.R. 4242: Orphan Drug Innovation Act](https://openamerica.io/bill/106-HR-4242/)